ProShare Advisors’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-37,554
Closed -$891K 1988
2023
Q3
$891K Buy
+37,554
New +$707K ﹤0.01% 742
2022
Q2
Sell
-12,466
Closed -$261K 2210
2022
Q1
$261K Sell
12,466
-1,854
-13% -$35.5K ﹤0.01% 1733
2021
Q4
$254K Buy
+14,320
New +$230K ﹤0.01% 1888
2021
Q3
Sell
-16,082
Closed -$267K 2328
2021
Q2
$267K Sell
16,082
-472
-3% -$8.46K ﹤0.01% 1966
2021
Q1
$300K Buy
16,554
+3,130
+23% +$61.8K ﹤0.01% 1805
2020
Q4
$245K Buy
+13,424
New +$213K ﹤0.01% 1744
2015
Q2
Sell
-10,808
Closed -$173K 1802
2015
Q1
$173K Sell
10,808
-1,020
-9% -$16.9K ﹤0.01% 1739
2014
Q4
$184K Sell
11,828
-9,092
-43% -$133K ﹤0.01% 1755
2014
Q3
$288K Sell
20,920
-5,119
-20% -$77.7K ﹤0.01% 1748
2014
Q2
$418K Sell
26,039
-15,311
-37% -$242K 0.01% 1695
2014
Q1
$698K Buy
+41,350
New +$750K 0.01% 1603
2013
Q4
Sell
-26,150
Closed -$568K 1956
2013
Q3
$568K Sell
26,150
-1,161
-4% -$24.8K 0.01% 1354
2013
Q2
$511K Buy
+27,311
New +$498K 0.01% 1319

Other funds holding NXGN

ProShare Advisors's NXGN Position: Q4 2023 in Review

ProShare Advisors sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 37,554 shares — an estimated $891K sold.

ProShare Advisors first reported a position in NXGN in Q2 2013 and held it in 13 quarters. The position peaked at $891K in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • ProShare Advisors reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • ProShare Advisors sold 37,554 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $891K.
  • ProShare Advisors first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
  • ProShare Advisors's NextGen Healthcare, Inc. Common Stock position peaked at $891K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on ProShare Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.